Search Results - "SIMON, Ronald"

Food allergy: A practice parameter update—2014 by Sampson, Hugh A., MD, Aceves, Seema, MD, PhD, Bock, S. Allan, MD, James, John, MD, Jones, Stacie, MD, Lang, David, MD, Nadeau, Kari, MD, PhD, Nowak-Wegrzyn, Anna, MD, Oppenheimer, John, MD, Perry, Tamara T., MD, Randolph, Christopher, MD, Sicherer, Scott H., MD, Simon, Ronald A., MD, Vickery, Brian P., MD, Wood, Robert, MD, Bernstein, David, MD, Blessing-Moore, Joann, MD, Khan, David, MD, Nicklas, Richard, MD, Portnoy, Jay, MD, Schuller, Diane, MD, Spector, Sheldon, MD, Tilles, Stephen A., MD, Wallace, Dana, MD

“…This parameter was developed by the Joint Task Force on Practice Parameters, representing the American Academy of Allergy, Asthma & Immunology (AAAAI); the…”
Get full text

The united allergic airway: connections between allergic rhinitis, asthma, and chronic sinusitis by Feng, Charles H, Miller, Michaela D, Simon, Ronald A

“…The united allergic airway is a theory that connects allergic rhinitis (AR), chronic rhinosinusitis, and asthma, in which seemingly disparate diseases, instead…”
Get full text

Safety and outcomes of aspirin desensitization for aspirin-exacerbated respiratory disease: A single-center study by Waldram, Jeremy, MD, Walters, Kristen, MD, Simon, Ronald, MD, Woessner, Katherine, MD, Waalen, Jill, MD, MPH, White, Andrew, MD

“…Background Aspirin desensitization is an effective treatment option for aspirin-exacerbated respiratory disease. Aspirin desensitization protocol modifications…”
Get full text

High Ki67 expression is an independent good prognostic marker in colorectal cancer by Melling, Nathaniel, Kowitz, Charlotte Marie, Simon, Ronald, Bokemeyer, Carsten, Terracciano, Luigi, Sauter, Guido, Izbicki, Jakob Robert, Marx, Andreas Holger

“…To correlate Ki67 expression with outcome in colorectal cancer (CRC). Ki67 labelling index (Ki67LI) was analysed by immunohistochemistry on a tissue microarray…”
Get more information

Guidelines for the Diagnosis and Management of Food Allergy in the United States: Report of the NIAID-Sponsored Expert Panel by FAUCI, Antony S

“…Food allergy is an important public health problem that affects children and adults and may be increasing in prevalence. Despite the risk of severe allergic…”
Get full text

Clinical Utility of Quantitative Gleason Grading in Prostate Biopsies and Prostatectomy Specimens by Sauter, Guido, Steurer, Stefan, Clauditz, Till Sebastian, Krech, Till, Wittmer, Corinna, Lutz, Florian, Lennartz, Maximilian, Janssen, Tim, Hakimi, Nayira, Simon, Ronald, von Petersdorff-Campen, Mareike, Jacobsen, Frank, von Loga, Katharina, Wilczak, Waldemar, Minner, Sarah, Tsourlakis, Maria Christina, Chirico, Viktoria, Haese, Alexander, Heinzer, Hans, Beyer, Burkhard, Graefen, Markus, Michl, Uwe, Salomon, Georg, Steuber, Thomas, Budäus, Lars Henrik, Hekeler, Elena, Malsy-Mink, Julia, Kutzera, Sven, Fraune, Christoph, Göbel, Cosima, Huland, Hartwig, Schlomm, Thorsten

“…Abstract Background Gleason grading is the strongest prognostic parameter in prostate cancer. Gleason grading is categorized as Gleason ≤6, 3 + 4, 4 + 3, 8,…”
Get full text

Improvement in Asthma Control Using a Minimally Burdensome and Proactive Smartphone Application by Cook, Kevin A., MD, Modena, Brian D., MD, Simon, Ronald A., MD

“…Background Integrated chronic disease treatment models that enable patient self-care and shared treatment decision making have recently been shown to improve…”
Get full text

Extreme intratumour heterogeneity and driver evolution in mismatch repair deficient gastro-oesophageal cancer by von Loga, Katharina, Woolston, Andrew, Punta, Marco, Barber, Louise J., Griffiths, Beatrice, Semiannikova, Maria, Spain, Georgia, Challoner, Benjamin, Fenwick, Kerry, Simon, Ronald, Marx, Andreas, Sauter, Guido, Lise, Stefano, Matthews, Nik, Gerlinger, Marco

“…Mismatch repair deficient (dMMR) gastro-oesophageal adenocarcinomas (GOAs) show better outcomes than their MMR-proficient counterparts and high immunotherapy…”
Get full text

Intralymphatic Immunotherapy for Peanut Allergy: A pilot study of three patients by Simon, Ronald A., Namazy, Jennifer A.

Get full text

Loss of CHD1 causes DNA repair defects and enhances prostate cancer therapeutic responsiveness by Kari, Vijayalakshmi, Mansour, Wael Yassin, Raul, Sanjay Kumar, Baumgart, Simon J, Mund, Andreas, Grade, Marian, Sirma, Hüseyin, Simon, Ronald, Will, Hans, Dobbelstein, Matthias, Dikomey, Ekkehard, Johnsen, Steven A

“…The CHD1 gene, encoding the chromo‐domain helicase DNA‐binding protein‐1, is one of the most frequently deleted genes in prostate cancer. Here, we examined the…”
Get full text

Intratumor DNA Methylation Heterogeneity Reflects Clonal Evolution in Aggressive Prostate Cancer by Brocks, David, Assenov, Yassen, Minner, Sarah, Bogatyrova, Olga, Simon, Ronald, Koop, Christina, Oakes, Christopher, Zucknick, Manuela, Lipka, Daniel Bernhard, Weischenfeldt, Joachim, Feuerbach, Lars, Cowper-Sal·lari, Richard, Lupien, Mathieu, Brors, Benedikt, Korbel, Jan, Schlomm, Thorsten, Tanay, Amos, Sauter, Guido, Gerhäuser, Clarissa, Plass, Christoph

“…Despite much evidence on epigenetic abnormalities in cancer, it is currently unclear to what extent epigenetic alterations can be associated with tumors’…”
Get full text

RAD51 overexpression is a negative prognostic marker for colorectal adenocarcinoma by Tennstedt, Pierre, Fresow, Robert, Simon, Ronald, Marx, Andreas, Terracciano, Luigi, Petersen, Cordula, Sauter, Guido, Dikomey, Ekkehard, Borgmann, Kerstin

“…RAD51 is the central protein in the homologous recombination pathway and is therefore of great relevance in terms of both therapy resistance as well as genomic…”
Get full text

Mitochondrial mutations drive prostate cancer aggression by Hopkins, Julia F., Sabelnykova, Veronica Y., Weischenfeldt, Joachim, Simon, Ronald, Aguiar, Jennifer A., Alkallas, Rached, Heisler, Lawrence E., Zhang, Junyan, Watson, John D., Chua, Melvin L. K., Fraser, Michael, Favero, Francesco, Lawerenz, Chris, Plass, Christoph, Sauter, Guido, McPherson, John D., van der Kwast, Theodorus, Korbel, Jan, Schlomm, Thorsten, Bristow, Robert G., Boutros, Paul C.

“…Nuclear mutations are well known to drive tumor incidence, aggression and response to therapy. By contrast, the frequency and roles of mutations in the…”
Get full text

Getting It Right for Our Patients: The Importance of Collaborative Leadership in the ICU by Savel, Richard H., Shiloh, Ariel L., Simon, Ronald J., Kupfer, Yizhak

Get full text

ERG Status Is Unrelated to PSA Recurrence in Radically Operated Prostate Cancer in the Absence of Antihormonal Therapy by MINNER, Sarah, ENODIEN, Malaika, BRASE, Jan C, LIU, Alvin Y, SCHLÜTER, Hartmut, PANTEL, Klaus, SCHUMACHER, Udo, BOKEMEYER, Carsten, STEUBER, Thomas, GRAEFEN, Markus, SAUTER, Guido, SCHLOMM, Thorsten, SIRMA, Hüseyin, LUEBKE, Andreas M, KROHN, Antje, MAYER, Pascale S, SIMON, Ronald, TENNSTEDT, Pierre, MÜLLER, Julia, SCHOLZ, Laura

“…About 50% of prostate cancers have TMPRSS2-ERG fusions with concurrent ERG overexpression. The aim of this study was to determine whether clinical differences…”
Get full text

Clopidogrel Desensitization: Background and Recommendations for Use of a Rapid (4 Hour) Protocol by Bulva, Jeffrey, Simon, Ronald A

“…The purpose of this section is to educate the reader on how to successfully manage patients with a hypersensitivity reaction to clopidogrel using…”
Get more information

Marked Prognostic Impact of Minimal Lymphatic Tumor Spread in Prostate Cancer by Wilczak, Waldemar, Wittmer, Corinna, Clauditz, Till, Minner, Sarah, Steurer, Stefan, Büscheck, Franziska, Krech, Till, Lennartz, Maximilian, Harms, Luisa, Leleu, Diane, Ahrens, Marc, Ingwerth, Sebastian, Günther, Christian T., Koop, Christina, Simon, Ronald, Jacobsen, Frank, Tsourlakis, Maria C., Chirico, Viktoria, Höflmayer, Doris, Vettorazzi, Eik, Haese, Alexander, Steuber, Thomas, Salomon, Georg, Michl, Uwe, Budäus, Lars, Tilki, Derya, Thederan, Imke, Fraune, Christoph, Göbel, Cosima, Henrich, Marie-Christine, Juhnke, Manuela, Möller, Katharina, Bawahab, Ahmed Abdullah, Uhlig, Ria, Adam, Meike, Weidemann, Sören, Beyer, Burkhard, Huland, Hartwig, Graefen, Markus, Sauter, Guido, Schlomm, Thorsten

“…Nodal metastasis (N1) is a strong prognostic parameter in prostate cancer; however, lymph node evaluation is always incomplete. To study the prognostic value…”
Get full text

Diagnostic and prognostic impact of cytokeratin 18 expression in human tumors: a tissue microarray study on 11,952 tumors by Menz, Anne, Weitbrecht, Timo, Gorbokon, Natalia, Büscheck, Franziska, Luebke, Andreas M, Kluth, Martina, Hube-Magg, Claudia, Hinsch, Andrea, Höflmayer, Doris, Weidemann, Sören, Fraune, Christoph, Möller, Katharina, Bernreuther, Christian, Lebok, Patrick, Clauditz, Till, Sauter, Guido, Uhlig, Ria, Wilczak, Waldemar, Steurer, Stefan, Minner, Sarah, Burandt, Eike, Krech, Rainer, Dum, David, Krech, Till, Marx, Andreas, Simon, Ronald

“…Cytokeratin 18 (CK18) is an intermediate filament protein of the cytokeratin acidic type I group and is primarily expressed in single-layered or "simple"…”
Get full text

SCRIB expression is deregulated in human prostate cancer, and its deficiency in mice promotes prostate neoplasia by Pearson, Helen B, Perez-Mancera, Pedro A, Dow, Lukas E, Ryan, Andrew, Tennstedt, Pierre, Bogani, Debora, Elsum, Imogen, Greenfield, Andy, Tuveson, David A, Simon, Ronald, Humbert, Patrick O

“…Loss of cellular polarity is a hallmark of epithelial cancers, raising the possibility that regulators of polarity have a role in suppressing tumorigenesis…”
Get full text

HER-2 amplification is highly homogenous in gastric cancer by Marx, Andreas H., MD, Tharun, Lars, Muth, Johanna, Dancau, Ana-Maria, MD, Simon, Ronald, PhD, Yekebas, Emre, MD, Kaifi, Jussuf T., MD, Mirlacher, Martina, Brümmendorf, Tim H., MD, Bokemeyer, Carsten, MD, Izbicki, Jakob R., MD, Sauter, Guido, MD

“…Summary Her-2 is the molecular target for antibody-based treatment of breast cancer (trastuzumab). The potential benefit of anti–Her-2 therapy is currently…”
Get full text